YTOT(300790)

Search documents
宇瞳光学:东兴证券关于宇瞳光学创业板向不特定对象发行可转换公司债券之发行保荐书
2023-08-08 12:11
东兴证券股份有限公司 关于 东莞市宇瞳光学科技股份有限公司 创业板向不特定对象发行可转换公司债券 之 发行保荐书 保荐机构(主承销商) (住所:北京市西城区金融大街 5 号新盛大厦 B 座 12、15 层) 二零二三年八月 东莞市宇瞳光学科技股份有限公司向不特定对象发行可转换公司债券申请文件 发行保荐书 声 明 东兴证券股份有限公司(以下简称"保荐机构"、"东兴证券")接受东莞市 宇瞳光学科技股份有限公司(以下简称"宇瞳光学"、"公司"或"发行人")的 委托,担任其向不特定对象发行可转换公司债券的保荐机构。 本保荐机构及保荐代表人已根据《中华人民共和国公司法》《中华人民共和 国证券法》《证券发行上市保荐业务管理办法》《上市公司证券发行注册管理办法》 (以下简称"《再融资注册办法》")、《深圳证券交易所创业板股票上市规则》等 有关法律、行政法规和中国证券监督管理委员会(下称"中国证监会")、深圳证 券交易所的规定,诚实守信,勤勉尽责,严格按照依法制订的业务规则、行业执 业规范和道德准则出具本发行保荐书,并保证所出具文件真实、准确和完整。 本发行保荐书中如无特别说明,相关用语与《东莞市宇瞳光学科技股份有限 公司创 ...
宇瞳光学:向不特定对象发行可转换公司债券网上路演公告
2023-08-08 12:11
证券代码:300790 证券简称:宇瞳光学 公告编号:2023-048 东莞市宇瞳光学科技股份有限公司 向不特定对象发行可转换公司债券网上路演公告 保荐人(主承销商):东兴证券股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 东莞市宇瞳光学科技股份有限公司(以下简称"发行人")向不特定对象发 行 60,000 万元可转换公司债券(以下简称"本次发行")已获得中国证券监督 管理委员会证监许可〔2023〕1382 号文予以注册。 本次发行的可转换公司债券向发行人在股权登记日收市后中国证券登记结 算有限责任公司深圳分公司登记在册的原股东优先配售,原股东优先配售后余额 部分(含原股东放弃优先配售部分)通过深圳证券交易所交易系统网上向社会公 众投资者发行。 本次发行的《募集说明书提示性公告》已于 2023 年 8 月 9 日(T-2 日)刊 登在《中国证券报》上,投资者亦可在巨潮资讯网(www.cninfo.com.cn)查询 募集说明书全文及本次发行的相关资料。 (此页无正文,为《东莞市宇瞳光学科技股份有限公司向不特定对象发行可转换 公司债券网上路演公告》 ...
宇瞳光学:国浩律师(广州)事务所关于宇瞳光学向不特定对象发行可转换公司债券的法律意见书及历次补充法律意见书
2023-08-08 12:11
国浩律师(广州)事务所 关于东莞市宇瞳光学科技股份有限公司 2022 年申请向不特定对象发行可转换公司债券的 关于东莞市宇瞳光学科技股份有限公司 2022 年申请向不特定对象发行可转换公司债券的 法 律 意 见 东莞市宇瞳光学科技股份有限公司: 法律意见 北京 上海 深圳 杭州 广州 昆明 天津 成都 宁波 福州 西安 南京 南宁 济南 重庆 苏州 长沙 太原 武汉 贵阳 乌鲁木齐 郑州 石家庄 合肥海南香港 巴黎 马德里 硅谷 斯德哥尔摩 纽约 地址:广州市天河区珠江东路 28 号越秀金融大厦 38 楼 邮编:510623 电话:+8620 38799345 传真:+8620 38799345-200 网址:http://www.grandall.com.cn 4-1-1 国浩律师(广州)事务所 (引言) 一、出具本法律意见书的依据 (一)按照东莞市宇瞳光学科技股份有限公司(以下简称"发行人")与本所订 立的《聘请专项法律顾问合同》的约定,本所指派周姗姗、钟成龙律师(以下简 称"本所律师")担任发行人本次申请向不特定对象发行可转换公司债券(以下简 称"本次发行")的专项法律顾问,参与相关工作并出具本法律意见 ...
宇瞳光学:向不特定对象发行可转换公司债券募集说明书提示性公告
2023-08-08 12:11
证券代码:300790 证券简称:宇瞳光学 公告编号:2023-047 东莞市宇瞳光学科技股份有限公司 向不特定对象发行可转换公司债券募集说明书提示性公告 保荐人(主承销商):东兴证券股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 东莞市宇瞳光学科技股份有限公司(以下简称"发行人"或"宇瞳光学") 向不特定对象发行 60,000.00 万元可转换公司债券(以下简称"本次发行")已 获得中国证券监督管理委员会证监许可〔2023〕1382 号文予以注册。 本次向不特定对象发行可转换公司债券将向股权登记日(即 2023 年 8 月 10 日,T-1 日)收市后登记在册的发行人原股东优先配售,优先配售后余额部分(含 原股东放弃优先配售部分)采用网上向社会公众投资者通过深圳证券交易所(以 下简称"深交所")交易系统发售的方式进行。 本次向不特定对象发行可转换公司债券募集说明书全文及相关资料可在巨 潮资讯网(www.cninfo.com.cn)查询。 (三)票面金额和发行价格 本次发行的可转换公司债券每张面值人民币 100 元,按面值发行。 1 (四)债券期 ...
宇瞳光学:宇瞳光学创业板向不特定对象发行可转换公司债券募集说明书
2023-08-08 12:11
东莞市宇瞳光学科技股份有限公司 (广东省东莞市长安镇靖海东路 99 号) 创业板向不特定对象发行可转换公司债券 募集说明书 (北京市西城区金融大街 5 号新盛大厦 B 座 12、15 层) 二〇二三年八月 东莞市宇瞳光学科技股份有限公司创业板向不特定对象发行可转换公司债券募集说明书 股票代码:300790 股票简称:宇瞳光学 保荐机构(主承销商) 东莞市宇瞳光学科技股份有限公司创业板向不特定对象发行可转换公司债券募集说明书 声 明 本公司及全体董事、监事、高级管理人员承诺募集说明书及其他信息披露资 料不存在任何虚假记载、误导性陈述或重大遗漏,并对其真实性、准确性及完整 性承担相应的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人保证募集说明书中财务 会计资料真实、完整。 中国证监会、交易所对本次发行所作的任何决定或意见,均不表明其对申请 文件及所披露信息的真实性、准确性、完整性作出保证,也不表明其对发行人的 盈利能力、投资价值或者对投资者的收益作出实质性判断或者保证。任何与之相 反的声明均属虚假不实陈述。 投资者认购或持有本次公司债券视作同意债券受托管理协议、债券持有人会 议规则及债券募集说明书中其 ...
宇瞳光学:宇瞳光学业绩说明会、路演活动等
2023-05-11 04:31
证券代码:300790 证券简称:宇瞳光学 东莞市宇瞳光学科技股份有限公司投资者关系活动记录表 编号:2023-003 | | □特定对象调研 □分析师会议 | | --- | --- | | 投资者关系 | □媒体采访 ☑业绩说明会 | | | □新闻发布会 □路演活动 | | 活动类别 | □现场参观 | | | □其他 (请文字说明其他活动内容) | | 参与单位名称及 | | | | 投资者网上提问 | | 人员姓名 | | | 时间 | 2023 年 5 月 10 日 (周五) 下午 15:00-17:00 | | | 通过全景网"投资者关系互动平台"(https://ir.p5w.net)采用网络远程的方式召 | | 地点 | 开业绩说明会 | | 上市公司接待人 | 董事长张品光、董事总经理金永红、副总经理董事会秘书陈天富、财务负责人 | | | 管秋生、独立董事阎磊、保荐代表人吴梅山 | | 员姓名 | | | | Q1:现在几乎越来越多家庭都在安装安防监控设备,是否有利于贵公司? | | | 跟华为又有哪些合作关系? | | | 光学镜头在智能家居方面的应用场景主要有小型安防监控摄影机、智能 ...
宇瞳光学(300790) - 宇瞳光学调研活动信息
2023-05-10 08:18
证券代码:300790 证券简称:宇瞳光学 编号:2023-002 | --- | --- | --- | |------------|---------------|----------------------------| | | ☑特定对象调研 | □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系 | | | | | □新闻发布会 | 路演活动 | | 活动类别 | | | | | ☑现场参观 | | | | 其他 | (请文字说明其他活动内容) | 海富通 王经纬 开源证券 刘翔、曹旭辰、景宗阳、李凰 浦银安盛 郑敏宏、罗雯、杨岳斌 国投瑞银 苏超、黄雪雨 中融基金 陈祖睿、甘传琦 长江证券 杨洋、蔡少东、谢尔曼 银华基金 王卓立、徐亦珉 前海开源 田维 光大证券 何昊 参与单位名称及 光大永明 刘奇 人员姓名 中信证券 丁科翔、陶然 东莞证券 刘梦麟、罗炜斌、谢少威 华商基金 黄润 银海基金 爱心觉罗.雍心 宝盈基金 容志能、张天闻 财通证券 张益敏、李琦 兴业基金 肖滨、吴渊 博时基金 刘锴、张健、李宜泽 海通国际 张晓飞 信达证券 郭一江 东莞市宇瞳光学科技股份有限公司 ...
宇瞳光学(300790) - 2023 Q1 - 季度财报
2023-04-27 16:00
Financial Performance - The company's revenue for Q1 2023 was CNY 410,671,618.86, a decrease of 4.60% compared to CNY 430,474,186.09 in the same period last year[2] - Net profit attributable to shareholders was CNY 10,217,773.62, down 76.17% from CNY 42,876,325.98 year-on-year[2] - The company's basic earnings per share decreased by 76.33% to CNY 0.0315 from CNY 0.1997 in the same period last year[2] - The total operating revenue for Q1 2023 was CNY 410,671,618.86, a decrease of 4.0% compared to CNY 430,474,186.09 in the same period last year[20] - The total operating costs for Q1 2023 were CNY 408,825,183.03, an increase of 5.8% from CNY 386,269,392.64 in the previous year[20] - The company's net profit for Q1 2023 was CNY 9,627,874.12, a decrease of 77.54% compared to CNY 42,876,325.98 in Q1 2022[21] - Operating profit for Q1 2023 was CNY 10,744,182.56, down 77.87% from CNY 48,522,747.82 in the same period last year[21] - The total comprehensive income for Q1 2023 was CNY 9,589,490.49, significantly lower than CNY 42,853,879.29 in Q1 2022[22] Cash Flow and Assets - The net cash flow from operating activities increased by 190.52% to CNY 119,381,414.02, compared to CNY 41,092,636.34 in the previous year[2] - Cash and cash equivalents at the end of Q1 2023 amounted to CNY 377,534,544.35, up from CNY 311,464,051.08 at the beginning of the year, reflecting a growth of 21.2%[17] - The total assets at the end of the reporting period were CNY 4,373,154,235.66, reflecting a 2.29% increase from CNY 4,275,106,219.82 at the end of the previous year[2] - The total liabilities increased to CNY 2,453,203,647.03 from CNY 2,375,791,333.59, reflecting a growth of 3.2%[19] - The non-current assets totaled CNY 2,532,296,142.74, up from CNY 2,494,524,080.58, representing an increase of 1.5%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 13,973[10] - Zhang Pingguang holds 13.42% of shares, totaling 45,423,921 shares, with 29,387,500 shares pledged[10] - The top 10 shareholders collectively hold significant stakes, with the largest shareholder having 13.42%[10] - The company has a total of 34,067,941 shares under lock-up for Zhang Pingguang, with a release date set for June 24, 2024[13] - The number of shares held by the top 10 unrestricted shareholders includes Zhang Hao with 11,448,907 shares[10] - The company reported a total of 4,608,460 shares held by Huang Xiujun, with 4,463,400 shares pledged[11] - The company has implemented a stock incentive plan with a 36-month lock-up period for certain executives[13] - The total number of shares under lock-up for Jin Yonghong is 8,508,069, with a release date also set for June 24, 2024[13] - The company has a total of 10,815,340 shares under lock-up for departing executive Jiang Xianhai[13] - The company is subject to specific regulations regarding the release of locked shares based on performance and tenure[13] Operational Highlights - The company reported a significant increase in receivables financing by 30.98%, reaching CNY 225,867,257.78, attributed to an increase in bank acceptance bills received[5] - The company received government subsidies amounting to CNY 3,749,185.97, which contributed to the increase in other income by 87.84%[4][7] - The company’s financial expenses rose by 107.97% to CNY 12,894,234.18, primarily due to increased borrowing costs[7] - Research and development expenses in Q1 2023 were CNY 22,980,413.54, a decrease of 16.51% from CNY 27,610,532.99 in Q1 2022[21] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[2] Employee Compensation - The company reported a decrease in employee compensation payable from CNY 43,893,199.54 to CNY 21,255,656.89, a reduction of 51.5%[19]
宇瞳光学(300790) - 2022 Q4 - 年度财报
2023-04-20 16:00
Financial Performance - The company reported a revenue of 1.2 billion RMB for the year 2022, representing a year-over-year increase of 15%[20]. - The net profit for 2022 was 200 million RMB, which is a 10% increase compared to the previous year[20]. - The company's operating revenue for 2022 was CNY 1,846,170,347, a decrease of 10.46% compared to CNY 2,061,738,934 in 2021[25]. - The net profit attributable to shareholders for 2022 was CNY 144,162,328.07, down 40.59% from CNY 242,660,282.15 in 2021[25]. - The net profit after deducting non-recurring gains and losses was CNY 100,453,612.36, a decline of 57.16% from CNY 234,501,176.97 in 2021[25]. - The company reported a total revenue of 1,610 million in 2022, representing a year-on-year increase of 63.76% compared to 801.95 million in 2021[128]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the fiscal year 2022, representing a year-over-year growth of 20%[140]. - The company reported a total revenue of 1.5 billion yuan for the fiscal year 2022, representing a year-over-year growth of 20%[186]. - The company provided a positive outlook for 2023, projecting a revenue growth of 15% to 1.725 billion yuan, driven by new product launches and market expansion efforts[184]. User Growth - User data showed a growth in active users by 25%, reaching a total of 5 million users by the end of 2022[20]. - User data indicates a growth in active users, reaching 5 million by the end of 2022, which is a 15% increase compared to the previous year[140]. - The company experienced a significant increase in user data, with a total of 34,200 active users, up from 25,650 in the previous year, marking a growth of approximately 33.5%[128]. Research and Development - The company plans to invest 300 million RMB in R&D for new product development in 2023, focusing on advanced optical technologies[20]. - The company's R&D expenditure in 2022 was CNY 133.31 million, focusing on key projects and accelerating the industrialization process, resulting in the recognition of several high-tech products[59]. - The company has invested in R&D, holding a total of 432 patents, including 35 invention patents, 329 utility model patents, and 68 design patents, enhancing its competitive edge in high-end products[52]. - Research and development expenses were ¥133,307,360.33, showing a slight decrease of 0.24% from ¥133,631,300.38 in 2021[74]. - Investment in R&D increased by 30% year-over-year, totaling 300 million yuan, focusing on innovative optical technologies and product enhancements[184]. Market Expansion - Future guidance indicates an expected revenue growth of 20% for 2023, driven by new product launches and market expansion[20]. - The company aims to expand its market presence in Southeast Asia, targeting a 15% market share by 2025[20]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2023[140]. - The company is exploring potential acquisitions to enhance its market position and expand its product offerings[20]. - A strategic acquisition of a local optical technology firm was completed, expected to enhance product offerings and increase competitive advantage[184]. Manufacturing and Production - A new manufacturing facility is set to be established in 2023, with an investment of 500 million RMB aimed at increasing production capacity[20]. - The company has expanded its production capacity with facilities in Dongguan and Shangrao, optimizing its manufacturing processes to support large-scale production and rapid delivery[53]. - The company has established a strong presence in the automotive optical business, supplying products to Tesla's supply chain and having indirect or direct usage in BYD, which is expected to contribute to significant revenue growth[51]. Financial Management - The company has no plans to distribute cash dividends or issue bonus shares for the fiscal year 2022[5]. - The company has implemented a stock incentive plan, granting 1.57 million restricted shares to 26 individuals, aligning employee interests with company performance[61]. - The company has a clear and transparent profit distribution plan that aligns with its articles of association and shareholder resolutions[159]. - The company plans to distribute at least 10% of the distributable profits as cash dividends annually, provided that cash dividend conditions are met[190]. Risk Management - The management highlighted potential risks including market competition and supply chain disruptions, with strategies in place to mitigate these risks[4]. - The company faces risks in technology development, customer concentration, quality management, and core talent retention, and is taking measures to mitigate these risks[109][110][111][112]. Corporate Governance - The company has established a transparent performance evaluation and incentive mechanism, launching two stock incentive plans since its listing to enhance employee motivation[122]. - The governance structure complies with relevant laws and regulations, with the board consisting of 8 members, including 3 independent directors, ensuring independent operation[119]. - The company has improved its information disclosure practices, ensuring timely and accurate communication with investors through various channels[123]. - The company maintains independence from its largest shareholder, ensuring no interference in decision-making processes[118]. Social Responsibility - The company actively fulfills social responsibilities by providing numerous job positions and various training programs for graduates, contributing positively to alleviating social employment pressure[177]. - The company has engaged in social welfare activities, including donations to local schools and community organizations, demonstrating a commitment to public welfare[178]. - The company has established strong ties with local governments and social organizations to support educational and skill development initiatives[180].
宇瞳光学:关于举行2022年度网上业绩说明会的公告
2023-04-20 10:28
证券代码:300790 证券简称:宇瞳光学 公告编号:2023-021 特此公告。 东莞市宇瞳光学科技股份有限公司董事会 2023 年 4 月 20 日 东莞市宇瞳光学科技股份有限公司 为便于广大投资者进一步了解公司 2022 年年度报告及经营管理情况,公司定于 2023 年 5 月 10 日(星期三)15:00 至 17:00 在全景网举办 2022 年度网上业绩说明会。 本次年度业绩说明会将采用网络远程的方式举行,投资者可登陆"投资者关系互动平台" (http://ir.p5w.net)参与本次年度业绩说明会。 出席本次业绩说明会的人员有:公司董事长张品光先生,董事、总经理金永红先生, 副总经理、董事会秘书陈天富先生,财务负责人管秋生先生,独立董事阎磊先生及保荐 代表人吴梅山先生。 为充分尊重投资者、提升交流的针对性,现就公司 2022 年度业绩说明会提前向投 资者公开征集问题,广泛听取投资者的意见和建议。投资者可于 2023 年 5 月 10 日(星 期三)15:00 前,将关注的问题通过(http://ir.p5w.net)界面的提问通道进行提问, 公司将在本次业绩说明会上对投资者普遍关注的问题进行重 ...